I was listening to the business of biotech podcast while running on Monday, where Allan Shaw a biotech CFO was being interviewed. He made a point around how he would pick a great team with mediocre asset before a great asset with mediocre team, as the great team will find a way to create value.
I think in this case, we have an all-star team for this specific space, and an asset which has been promising thus far and appears to be differentiated. I am excited for the future!
CHM Price at posting:
25.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)